India
· Delayed Price · Currency is INR Gland Pharma Company Description
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.
The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services.
The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
| Country | India |
| Founded | 1978 |
| Industry | Pharmaceutical Preparations |
| Employees | 4,217 |
| CEO | Srinivas Sadu |
Contact Details
Address: Plot No. 11 & 84, TSIIC Phase: IV Hyderabad, 502307 India | |
| Phone | 91 84 5569 9999 |
| Website | glandpharma.com |
Stock Details
| Ticker Symbol | 543245 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Srinivas Sadu | Chief Executive Officer |
| Ravi Mitra | Chief Financial Officer |
| Satnam Loomba | Chief Operating Officer |
| Ankit Gupta | Head of Investor Relations |